📰 B Biontech News
Page 2 - B Biontech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from B Biontech. Real-time updates on events, politics, business and more.
March 18, 2022
Drugmaker Moderna asked the Food and Drug Administration on Thursday to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults.
March 18, 2022
Drugmaker Moderna asked the Food and Drug Administration on Thursday to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults.
February 11, 2022
Health officials are coming to realize that while pushing COVID-19 vaccines to the market in record time likely saved hundreds of thousands of lives in America, it also meant they didn't get the dosing decisions exactly right.
February 11, 2022
Health officials are coming to realize that while pushing COVID-19 vaccines to the market in record time likely saved hundreds of thousands of lives in America, it also meant they didn't get the dosing decisions exactly right.
February 1, 2022
Pfizer and BioNTech are reportedly preparing to ask the Food and Drug Administration to authorize a COVID-19 vaccine for kids younger than 5.
February 1, 2022
Pfizer and BioNTech are reportedly preparing to ask the Food and Drug Administration to authorize a COVID-19 vaccine for kids younger than 5.
January 26, 2022
Dr. Anthony Fauci said it's "prudent" to "prepare" a vaccine that specifically targets omicron. Then in the next breath, he said it's not necessarily necessary. And with that, bam -- Fauci brings his trademark flip-floppiness to America's COVID-19 stage.
January 25, 2022
Pfizer and BioNTech on Tuesday launched a clinical study to evaluate the safety and efficacy of a COVID-19 vaccine that targets omicron, the globally dominant variant.
January 25, 2022
Pfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the hugely contagious omicron variant.
January 25, 2022
Pfizer and BioNTech on Tuesday launched a clinical study to evaluate the safety and efficacy of a COVID-19 vaccine that targets omicron, the globally dominant variant.